Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Aortic Valve Stenosis with Hypertension. The double loaded ventricle Javier Bermejo DEPARTMENT OF CARDIOLOGY I have no financial relationships to disclose The Problem AS CAD - AS is present in 1-3 % of pts. with HT - HT is present in 30-60 % of pts. with AS - HT is a “risk factor” for degenerative AS - Common findings are disruption of elastic fibers Hypertension The double loaded ventricle Aortic Valve Arterial Bed AS & Hypertension Diagnostic implications Physiological consequences Impact on outcome Therapeutic issues In the Echo-Lab: Measure BP in all pts. with AS Reassess severity if extreme values + JACC 2005 Briand et al JACC 2005 Hachicha Circulation 2007 Rosebbo N Engl J Med 2008 Carmaruic JACC Img 2009 Jander et al Circulation 2011 Rieck et al Hypertension 2012 Rieck et al Hypertension 2012 Rieck et al Hypertension 2012 Treat Hypertension! brain/ kidney other vascular beds brain/ kidney other vascular beds Courtesy of MF O’Rourke Target for drug therapy • • • • • • • N= 20 pts. with severe AS & HT 73 years old (87 – 29) 13 male / 7 female AVA= 0.7 ± 0.3 cm2 Normal EF Stress Echocardiography Randomized with/without - test/retest Jiménez Candil et al. Heart 2005 Jiménez Candil et al. Heart 2005 Nadir et al. JACC 2011 Nadir et al. JACC 2011 Treat Aortic Valve Stenosis… (if symptomatic) Circulation Research 1992 Valvular and Ventricular Aortic Valve Area (cm2) Mean Transvalvular Pressure Gradient (mm Hg) Stroke Volume (ml) Ejection Fraction (%) LV End-systolic Elastance (mm Hg/ml) LV pressure (mmHg) Vascular Mean Blood Pressure (mmHg) Pulse Pressure (mmHg) Systemic Vascular Resistance (dynes/s/cm-5) Aortic Input Impedance Z1 (mmHg/ml) Characteristic Impedance (dynes/s/cm-5) Aortic Compliance (·10-3 cm5/dynes) Ea (mmHg/ml) Ea/Ees Non-Invasive Valvuloarterial Impedance (mmHg/ml) Wave Intensity Analysis Wave Speed (m/s) Peak dIw FCW (· 106 W·m-2·s-2) Reflexion Distance (m) *Wilcoxon test Pre-TAVI Post-TAVI p* 0.7 ± 0.1 39 ± 18 75 ± 13 47 ± 21 0.76 ± 0.2 128 ± 18 1.8 ± 0.6 11 ± 4 64 ± 17 55 ± 17 1.3 ± 0.7 115 ± 25 0.007 0.005 0.14 0.038 0.09 0.12 62 ± 14 39 ± 13 820 ± 259 337 ± 142 147 ± 78 1.47 ± 0.78 1.05 ± 0.30 1.38 ± 0.37 2.1 ± 0.5 74 ± 17 52 ± 14 1137 ± 597 510 ± 188 207 ± 109 0.80 ± 0.27 1.61 ± 0.63 1.38 ± 0.23 1.9 ± 0.9 0.05 0.005 0.08 0.028 0.14 0.08 0.023 0.92 0.5 2.48 ± 1.18 4.06 ± 1.76 0.01 0.91 ± 0.49 0.06 ± 0.03 1.52 ± 0.78 0.08 ± 0.12 0.012 0.81 Yotti et al AHA 2012 Valve and the Arterial Bed: More than simple lumped-model LV load interaction after valve intervention Effects of Load in AS competititive complementary Dahl et al Am J Cardiol 2010 Treat them both! Dahl et al Am J Cardiol 2010 Conclusions (1/2) AS & HT are two highly prevalent diseases, with important interactions regarding pathophysiology, diagnosis, LV function, and outcome. In case of severe HT, reassess severity after controlling BP. Increased load reduces cardiac output and modifies LV remodelling response. Conclusions (2/2) HT in pts. with AS doubles the risk of hard CV events. HT should be aggressively treated ACEI and ARB are the drugs of choice. HT after AVR blunts the acute and chronic benefits of valvular interventions. Treatment is advocated for the long-term after AVR.